Earnings Feed
Start Free
Voyager Therapeutics, Inc.·4

Jun 11, 4:02 PM ET

Onyia Jude 4

4 · Voyager Therapeutics, Inc. · Filed Jun 11, 2026

Research Summary

AI-generated summary of this filing

Updated

Voyager Therapeutics (VYGR) Director Onyia Jude Receives 30,000-Share Option

What Happened
Onyia Jude, a director of Voyager Therapeutics, was granted a derivative award of 30,000 shares on 2026-06-09. The Form 4 shows an acquisition type "A" (award/grant) at $0.00 (no cash paid at grant). The award was filed on 2026-06-11.

Key Details

  • Transaction date: 2026-06-09; Form 4 filed: 2026-06-11 (appears timely).
  • Instrument: stock option award (derivative); reported as 30,000 shares at $0.00.
  • Vesting: per footnote F1, vesting commencement = grant date; all underlying shares vest upon the earlier of the one-year anniversary of the grant or the next annual meeting of stockholders, subject to continued service as a director.
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Remarks/Exhibits: Exhibit 24 (Power of Attorney) included.

Context
This is a director compensation award under Voyager’s 2025 Stock Incentive Plan (routine for board members). It is an option/award grant—no immediate sale or purchase of common stock—so it reflects compensation rather than an open-market investment by the insider.

Insider Transaction Report

Form 4
Period: 2026-06-09
Voyager Therapeutics, Inc.VYGR
Onyia Jude
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    [F1]
    2026-06-09+30,000→ 30,000 total
    Exercise: $3.43Exp: 2036-06-09→ Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the "Vesting Commencement Date") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director.
Signature
/s/ Gregory L. Shiferman, as Attorney-in-Fact for Jude Onyia|2026-06-11

Documents

2 files